In tamoxifen-resistant MCF-7 breast cancer cells, SIRT1 inhibition reduces nuclear FOXO1 levels and the expression of downstream resistance protein 2 (Choi et al., 2013). This evidence concerns the gene FOXO1 and breast carcinoma.